Trial Profile
To evaluate the effect of combination therapy of Continuous insulin infusion or continuous insulin infusion +Sitagliptin on glycemic Control in patients with newly diagnosed Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2016
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Oct 2016 New trial record